GEMTYLE 1000 Injection: Gemcitabine 1000 mg

Multi-Spectrum Efficacy: A Core Component in Cancer Protocols

The Mechanism: Inhibiting DNA Synthesis and Inducing Apoptosis

Standard of Care in Pancreatic, Lung, and Breast Cancer Management

High-Value Market: Injectable Oncology Demand in India
Secure Your Future: GEMTYLE 100 PCD Pharma Franchise with Monopoly

Home/Products /gemcitabine-1000mg-injection

About the Product

Description


GEMTYLE 1000 Injection (Gemcitabine 1000 mg) is a widely used and indispensable cytotoxic chemotherapy agent in modern oncology. Classified as an antimetabolite (a pyrimidine analog), it is crucial for the treatment of several aggressive malignancies, including: Pancreatic Cancer (as a monotherapy or in combination), Non-Small Cell Lung Cancer (NSCLC) (in combination with cisplatin), Ovarian Cancer (in combination with carboplatin), and Metastatic Breast Cancer (in combination with paclitaxel).

Gemcitabine works as a prodrug, converting inside the cancer cell into active metabolites that inhibit DNA synthesis (masked chain termination) and block the enzyme ribonucleotide reductase. This dual action effectively slows or stops the growth and spread of cancer cells.

The demand for high-quality, generic injectable oncology products like Gemcitabine is consistently high, driven by the rising prevalence of cancer globally and the necessity of chemotherapy in standard treatment protocols. This places GEMTYLE 1000 in a high-demand, high-growth market segment. We offer a lucrative PCD Pharma Franchise opportunity with exclusive Monopoly Rights for Gemcitabine 1000 mg, ensuring competitive pricing, quality assurance, and comprehensive promotional support for targeted distribution to hospitals and oncology centers.

May cause headache, muscle pain, nausea, abdominal discomfort, or mild liver enzyme elevation. Rarely, serious muscle problems (myopathy or rhabdomyolysis) may occur.

Primary hypercholesterolemia Mixed dyslipidemia Familial hypercholesterolemia Prevention of cardiovascular disease in high-risk patients

Take under medical supervision, preferably once daily, with or without food. Regular liver function and lipid profile monitoring is advised. Inform your doctor about any muscle pain, weakness, or pre-existing liver/kidney conditions. Avoid excessive alcohol intake.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Gemcitabine 1000mg Injection in the PCD pharma franchise market?

Gemcitabine 1000mg Injection has strong demand in the oncology and hospital critical-care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer care, specialty hospitals, and institutional supply portfolios.

Why should medical distributors include Gemcitabine 1000mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for management of lung cancer, pancreatic cancer, breast cancer, bladder cancer, ovarian cancer, and other solid tumors under oncologist supervision. Gemcitabine 1000mg is an antineoplastic chemotherapy agent that interferes with cancer cell growth and replication Widely used in hospital-based oncology treatment protocols This strengthens a reliable oncology injectable portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Gemcitabine 1000mg Injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Gemcitabine 1000mg Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong oncology hospital demand, high-value institutional sales, specialty physician prescriptions, reliable supply chain support, and strong margins in oncology injectables.

How can I become a distributor or franchise partner for Gemcitabine 1000mg Injection?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.